Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimicsPeng Li, Manchao Zhang, Ya Qiu Long, et al.
Journal of Medicinal Chemistry|August 5, 2005
Design and synthesis of 4-(alpha-hydroxymalonyl)phenylalanine as a new phosphotyrosyl mimetic and its use in growth factor receptor bound 2 src-homology 2 (Grb2 SH2) domain-binding peptidesSang-Uk Kang, Karen M Worthy, Lakshman K Bindu, et al.
Bioorganic & Medicinal Chemistry|May 17, 2005
Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinityZhen-Dan Shi, Hongpeng Liu, Manchao Zhang, et al.
Psychology Research and Behavior Management|September 8, 2025
Food Intake and Mental Health Among Middle School Students in Shandong Province: A Network AnalysisYisong Yao, Baoyi Liao, Jingjing Feng, et al.
Genes|April 28, 2023
A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1Ye Hong, Zengfei Xia, Yuting Sun, et al.
Pancreas|October 14, 2009
Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cellsSanjeev Banerjee, Minsig Choi, Amro Aboukameel, et al.
Leukemia & Lymphoma|April 29, 2010
Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cellsIsmael J Samudio, Seshagiri Duvvuri, Karen Clise-Dwyer, et al.
Life Sciences|April 25, 2012
Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cellsNing-Ning Zhou, Jun Tang, Wen-Dan Chen, et al.
Clinical and Translational Science|September 4, 2024
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteersHengbang Wang, Yun Yang, Zi Chen, et al.
Molecular Cancer Therapeutics|February 17, 2005
(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancerLiang Xu, Dajun Yang, Shaomeng Wang, et al.
Pageof 12